Almirall, S.A. ( LBTSF) - Key Metrics
LBTSF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q4 | $2.55 | $0.09 | $0.53 | $0.42 |
| 2025Q3 | $1.22 | $0.06 | $0.42 | $0.56 |
| 2025Q2 | $1.29 | $0.02 | $0.15 | -$0.19 |
| 2025Q1 | $1.34 | $0.10 | $0.12 | $0.06 |
| 2024Q4 | $1.21 | $0.01 | $0.26 | -$0.29 |
LBTSF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q4 | ? | 35.12 |
| 2025Q3 | 0.02% | 49.00 |
| 2025Q2 | 526.15% | 114.01 |
| 2025Q1 | ? | 24.21 |
| 2024Q4 | 0.41% | 149.22 |
LBTSF Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2025Q4 | 3.25% | ? |
| 2025Q3 | 4.88% | 0.00% |
| 2025Q2 | -1.81% | 1.15% |
| 2025Q1 | 0.58% | ? |
| 2024Q4 | -3.46% | 0.00% |
LBTSF
Price: $15.35
Dividend Yield: 1.34%
Forward Dividend Yield: 1.34%
Dividend Per Share: 0.21 USD
Earnings Per Share: 0.26 USD
P/E Ratio: 59.04
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 3.3 billion
Average Dividend Frequency: 1
Years Paying Dividends: 8
DGR3: 2.16%
DGR5: 11.69%